Cargando…

The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis

To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics analysis for SARS-CoV-2-required genes and host genes and variants related to SARS-CoV-2 susceptibility and COVID-19 severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xinwei, Liang, Huazheng, Zhang, Hong, Tian, Li, Cong, Peilin, Wu, Tingmei, Zhang, Qian, Gao, Xiaofei, Li, Wanrong, Chen, Aiwen, Zhang, Yuxin, Dong, Qianyu, Wan, Hanxi, He, Mengfan, Dai, Danqing, Li, Zhen, Xiong, Lize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784815/
https://www.ncbi.nlm.nih.gov/pubmed/35082790
http://dx.doi.org/10.3389/fimmu.2021.804387
_version_ 1784638822867271680
author Huang, Xinwei
Liang, Huazheng
Zhang, Hong
Tian, Li
Cong, Peilin
Wu, Tingmei
Zhang, Qian
Gao, Xiaofei
Li, Wanrong
Chen, Aiwen
Zhang, Yuxin
Dong, Qianyu
Wan, Hanxi
He, Mengfan
Dai, Danqing
Li, Zhen
Xiong, Lize
author_facet Huang, Xinwei
Liang, Huazheng
Zhang, Hong
Tian, Li
Cong, Peilin
Wu, Tingmei
Zhang, Qian
Gao, Xiaofei
Li, Wanrong
Chen, Aiwen
Zhang, Yuxin
Dong, Qianyu
Wan, Hanxi
He, Mengfan
Dai, Danqing
Li, Zhen
Xiong, Lize
author_sort Huang, Xinwei
collection PubMed
description To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics analysis for SARS-CoV-2-required genes and host genes and variants related to SARS-CoV-2 susceptibility and COVID-19 severity. BLCA, HNSC, KIRC, KIRP, LGG, PCPG, PRAD, TGCT, and THCA patients carrying rs10774671-A (OAS1) genotype may be more likely to have poor COVID-19 outcomes relative to those who carry rs10774671-G, because individuals carrying rs10774671-A will have lower expression of OAS1, which serves as a protective factor against SARS-CoV-2 processes and poor COVID-19 outcomes. SARS-CoV-2-required genes were correlated with TME, immune infiltration, overall survival, and anti-cancer drug sensitivity. CHOL patients may have a higher risk of SARS-CoV-2 infection than healthy subjects. SARS-CoV-2-induced ACE2 and NPC1 elevation may have a negative influence on the immune responses of LUSC and CD8+T infiltration of LUAD, and negatively affect the sensitivity of anti-lung cancer drugs. LUSC and LUAD patients may have a varying degree of adverse outcomes if they are infected with SARS-CoV-2. miR-760 may target and inhibit ACE2 expression. Cancer patients appearing vulnerable to SARS-CoV-2 infection and having poor COVID-19 outcomes may be partly due to host genetic factors and dysregulation of SARS-CoV-2-required genes. OAS1, ACE2, and miR-760 could serve as the treatment and intervention targets for SARS-CoV-2.
format Online
Article
Text
id pubmed-8784815
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87848152022-01-25 The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis Huang, Xinwei Liang, Huazheng Zhang, Hong Tian, Li Cong, Peilin Wu, Tingmei Zhang, Qian Gao, Xiaofei Li, Wanrong Chen, Aiwen Zhang, Yuxin Dong, Qianyu Wan, Hanxi He, Mengfan Dai, Danqing Li, Zhen Xiong, Lize Front Immunol Immunology To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics analysis for SARS-CoV-2-required genes and host genes and variants related to SARS-CoV-2 susceptibility and COVID-19 severity. BLCA, HNSC, KIRC, KIRP, LGG, PCPG, PRAD, TGCT, and THCA patients carrying rs10774671-A (OAS1) genotype may be more likely to have poor COVID-19 outcomes relative to those who carry rs10774671-G, because individuals carrying rs10774671-A will have lower expression of OAS1, which serves as a protective factor against SARS-CoV-2 processes and poor COVID-19 outcomes. SARS-CoV-2-required genes were correlated with TME, immune infiltration, overall survival, and anti-cancer drug sensitivity. CHOL patients may have a higher risk of SARS-CoV-2 infection than healthy subjects. SARS-CoV-2-induced ACE2 and NPC1 elevation may have a negative influence on the immune responses of LUSC and CD8+T infiltration of LUAD, and negatively affect the sensitivity of anti-lung cancer drugs. LUSC and LUAD patients may have a varying degree of adverse outcomes if they are infected with SARS-CoV-2. miR-760 may target and inhibit ACE2 expression. Cancer patients appearing vulnerable to SARS-CoV-2 infection and having poor COVID-19 outcomes may be partly due to host genetic factors and dysregulation of SARS-CoV-2-required genes. OAS1, ACE2, and miR-760 could serve as the treatment and intervention targets for SARS-CoV-2. Frontiers Media S.A. 2022-01-10 /pmc/articles/PMC8784815/ /pubmed/35082790 http://dx.doi.org/10.3389/fimmu.2021.804387 Text en Copyright © 2022 Huang, Liang, Zhang, Tian, Cong, Wu, Zhang, Gao, Li, Chen, Zhang, Dong, Wan, He, Dai, Li and Xiong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Huang, Xinwei
Liang, Huazheng
Zhang, Hong
Tian, Li
Cong, Peilin
Wu, Tingmei
Zhang, Qian
Gao, Xiaofei
Li, Wanrong
Chen, Aiwen
Zhang, Yuxin
Dong, Qianyu
Wan, Hanxi
He, Mengfan
Dai, Danqing
Li, Zhen
Xiong, Lize
The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title_full The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title_fullStr The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title_full_unstemmed The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title_short The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
title_sort potential mechanism of cancer patients appearing more vulnerable to sars-cov-2 and poor outcomes: a pan-cancer bioinformatics analysis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784815/
https://www.ncbi.nlm.nih.gov/pubmed/35082790
http://dx.doi.org/10.3389/fimmu.2021.804387
work_keys_str_mv AT huangxinwei thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT lianghuazheng thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhanghong thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT tianli thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT congpeilin thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT wutingmei thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhangqian thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT gaoxiaofei thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT liwanrong thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT chenaiwen thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhangyuxin thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT dongqianyu thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT wanhanxi thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT hemengfan thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT daidanqing thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT lizhen thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT xionglize thepotentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT huangxinwei potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT lianghuazheng potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhanghong potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT tianli potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT congpeilin potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT wutingmei potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhangqian potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT gaoxiaofei potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT liwanrong potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT chenaiwen potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT zhangyuxin potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT dongqianyu potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT wanhanxi potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT hemengfan potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT daidanqing potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT lizhen potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis
AT xionglize potentialmechanismofcancerpatientsappearingmorevulnerabletosarscov2andpooroutcomesapancancerbioinformaticsanalysis